At Sun Pharma, our vision is the driving force behind our actions, and that’s where you come in. Follow us to find out what it’s really like to work here & more
When you represent your country at the top level, pain cannot be an excuse. Defeat pain instantly with India’s strongest pain relief spray* - Volini Maxx.
#myvolini@MyVolini
Sun Pharma bags CSR Award from the Federation of Gujarat Industries for outstanding contribution in the field of CSR. #wearesun
https://t.co/iGh7u004AT
Sun Pharma is listed among The World’s 100 Most Innovative Companies by
Forbes.
The World's Most Innovative Companies ranks the 100 firms with the best ideas via @forbes https://t.co/O4qwwYYxvz via @forbes
Sun Pharma announces US FDA approval of ILUMYA™ (#tildrakizumab-asmn) for the treatment of moderate-to-severe plaque #psoriasis
https://t.co/bsuZaLaKnw
Sun Pharma received ASSOCHAM Pharma Excellence Award 2018 for Best Innovations in API & Excipients from Director General of Health Services (DGHS), Govt. of India, Dr. Promila Gupta in New Delhi
“Our Q4 performance is in-line with our guidance. Over the last four quarters, we have been able to record a gradual improvement in performance despite a challenging US generic pricing environment." Dilip Shanghvi, Managing Director, Sun Pharma
Sun Pharma announces US FDA approval of YONSA (abiraterone acetate), a novel formulation in combination with methylprednisolone, for treatment of patients with metastatic castration-resistant prostate cancer.
https://t.co/PnpWbztIYP
Sun Pharma wins WIPO User’s Trophy emerging as Top Indian Company for creating Global Brand 2018. Department of Industrial Policy & Promotion (@DIPPGOI ) and World Intellectual Property Organization (@WIPO ) selected the company for the prestigious award. #wearesun
Sun Pharma Consumer Healthcare enters anti-fungal powder OTC category with #ABZORB. A 360 degree marketing campaign comprising TV, print & digital launched to expand consumer outreach.
https://t.co/pCXN7Um9k3
“We are excited to offer consumers the Brand of Choice by dermatologists – #ABZORB. The intent of the 360 degree marketing campaign is to raise consumer awareness regarding fungal infections & empower them to lead a healthier life.” - Vidhi Salgaocar, Head, Consumer Healthcare
Sun Pharma announces US FDA approval of ILUMYA™ (#tildrakizumab-asmn) for the treatment of moderate-to-severe plaque #psoriasis
https://t.co/V7tUIz2rB6
“With the approval of ILUMYA™ and our long-standing commitment in dermatology, we are focused on making a difference for people living with moderate-to-severe plaque #psoriasis,” - Abhay Gandhi, President & Chief Executive Officer, North America, Sun Pharma
“If you’re someone who wants see things through from ideation to implementation – there are a myriad of opportunities to work on transformational projects that span across functions and geographies.”